Initial results of pulmonary resection following neoadjuvant nivolumab in patients with resectable non-small cell lung cancer

OBJECTIVE: We conducted a phase I trial of neoadjuvant nivolumab, a monoclonal antibody to the PD-1 checkpoint receptor, in patients with resectable non-small cell lung cancer (NSCLC). We analyzed perioperative outcomes to assess the safety of this strategy. METHODS: Patients with untreated stage I-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Cardiovasc Surg
Main Authors: Bott, Matthew J., Yang, Stephen C., Park, Bernard J., Adusumilli, Prasad S., Rusch, Valerie W., Isbell, James M., Downey, Robert J., Brahmer, Julie R., Battafarano, Richard, Bush, Errol, Chaft, Jamie, Forde, Patrick M., Jones, David R., Broderick, Stephen R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653596/
https://ncbi.nlm.nih.gov/pubmed/30718052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.11.124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados